Unité de Gynécologie endocrinienne, Université Paris Descartes, APHP, Hôtel-Dieu, 1 place du Parvis Notre-Dame, Paris Cedex 4, France.
Gynecol Endocrinol. 2012 Nov;28(11):921-4. doi: 10.3109/09513590.2012.683075. Epub 2012 Jun 25.
To analyze the history of relapses in idiopathic granulomatous mastitis (IGM) and to define an appropriate therapeutic strategy. The duration and number of relapses are unpredictable, and the roles of surgery and corticosteroids remain controversial.
A series of 14 patients with IGM and a mean follow-up of 61.5 ± 73 (SD) months were retrospectively studied in the Gynecology Unit (Hotel Dieu Hospital, Paris, France). Main outcome measure was number of relapses per year before and following corticosteroid therapy. Comparison of the two groups was performed with matched t-test.
A total of 125 episodes were analyzed. Before steroid treatment, 60 recurrences occurred, corresponding to a mean of 4.03 ± 4.22 (SD) relapses per year. After the first treatment with prednisone, patients experienced 47 relapses, representing a mean of 1.11 ± 1.27 (SD) relapses per year (p = 0.0371).
Medical treatment with steroid reduces the duration and number of episodes. It also prevents the need for invasive breast surgery.
分析特发性肉芽肿性乳腺炎(IGM)的复发史,并确定合适的治疗策略。复发的持续时间和次数是不可预测的,手术和皮质类固醇的作用仍存在争议。
对 14 例 IGM 患者进行了回顾性研究,平均随访 61.5 ± 73(SD)个月,这些患者均在法国巴黎的妇产科医院(Hotel Dieu 医院)接受治疗。主要观察指标为皮质类固醇治疗前后每年的复发次数。采用配对 t 检验比较两组之间的差异。
共分析了 125 次发作。在类固醇治疗前,有 60 次复发,平均每年 4.03 ± 4.22(SD)次。首次使用强的松龙治疗后,患者经历了 47 次复发,平均每年 1.11 ± 1.27(SD)次(p = 0.0371)。
皮质类固醇的药物治疗可减少复发的持续时间和次数,还可预防需要进行侵入性乳房手术。